SCHEMBL8180758

SCHEMBL8180758

O=C(O)C1CCN(c2nc(NCc3ccccc3)c3cc(Cl)sc3n2)CC1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 2/20 0.54
PDE4B Q07343 2/20 0.54
PDE4C Q08493 2/20 0.54
PDE4D Q08499 2/20 0.54
HRH4 Q9H3N8 2/20 0.49
HTR3A P46098 1/20 0.49
CTNNB1 P35222 13/20 0.49
TCF7L2 Q9NQB0 13/20 0.49
KDM4E B2RXH2 1/20 0.48
MAPT P10636 1/20 0.48
MAPK1 P28482 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
PDE5A O76074 3/20 0.47
HTR2A P28223 1/20 0.46
DRD3 P35462 1/20 0.46
PDE2A O00408 1/20 0.46
PDE1A P54750 1/20 0.46
PDE1B Q01064 1/20 0.46
PDE1C Q14123 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8186066 0.92 PDE4A (0.53) PDE4APDE4BPDE4CPDE4DHRH4
SCHEMBL8179151 0.90 PDE4A (0.56) PDE4APDE4BPDE4CPDE4DHRH4
SCHEMBL8180828 0.89 MAPT (0.48) HRH4HTR3ACTNNB1TCF7L2MAPT
SCHEMBL8182382 0.89 CTNNB1 (0.51) PDE4APDE4BPDE4CPDE4DHRH4
SCHEMBL8171169 0.88 PDE4A (0.49) PDE4APDE4BPDE4CPDE4DHRH4
SCHEMBL7020325 0.88 HRH4 (0.47) PDE4APDE4BPDE4CPDE4DHRH4
SCHEMBL8181130 0.87 ICAM1 (0.51) PDE4APDE4BPDE4CPDE4DHRH4
SCHEMBL8184409 0.86 PDE4A (0.47) PDE4APDE4BPDE4CPDE4DHRH4
SCHEMBL8177126 0.86 PDE4A (0.52) PDE4APDE4BPDE4CPDE4DHRH4
SCHEMBL8184322 0.86 PDE4A (0.67) PDE4APDE4BPDE4CPDE4DCTNNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6130223-A Thienopyrimidine with phosphodiesterase V inhibiting effect MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2000-10-10 US disclosed
US-5948911-A Method for inhibiting neoplastic cells and related conditions by exposure to thienopyrimidine derivatives CELL PATHWAYS, INC. (US) 1999-09-07 US disclosed